Goldman Sachs’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $228K | Buy |
314,938
+143,151
| +83% | +$104K | ﹤0.01% | 4664 |
|
|
2025
Q1 | $148K | Sell |
171,787
-23,908
| -12% | -$20.6K | ﹤0.01% | 4743 |
|
|
2024
Q4 | $329K | Buy |
195,695
+33,367
| +21% | +$56.1K | ﹤0.01% | 4495 |
|
|
2024
Q3 | $463K | Buy |
162,328
+79,439
| +96% | +$226K | ﹤0.01% | 4149 |
|
|
2024
Q2 | $194K | Buy |
82,889
+19,853
| +31% | +$46.5K | ﹤0.01% | 4380 |
|
|
2024
Q1 | $185K | Sell |
63,036
-3,985
| -6% | -$11.7K | ﹤0.01% | 4350 |
|
|
2023
Q4 | $200K | Sell |
67,021
-13,665
| -17% | -$40.9K | ﹤0.01% | 4327 |
|
|
2023
Q3 | $255K | Sell |
80,686
-14,475
| -15% | -$45.7K | ﹤0.01% | 4176 |
|
|
2023
Q2 | $368K | Buy |
95,161
+3,396
| +4% | +$13.1K | ﹤0.01% | 4129 |
|
|
2023
Q1 | $254K | Buy |
91,765
+20,950
| +30% | +$58K | ﹤0.01% | 4419 |
|
|
2022
Q4 | $127K | Sell |
70,815
-3,752
| -5% | -$6.75K | ﹤0.01% | 4618 |
|
|
2022
Q3 | $158K | Sell |
74,567
-3,236
| -4% | -$6.86K | ﹤0.01% | 4794 |
|
|
2022
Q2 | $209K | Sell |
77,803
-15,761
| -17% | -$42.3K | ﹤0.01% | 4880 |
|
|
2022
Q1 | $406K | Buy |
93,564
+35,888
| +62% | +$156K | ﹤0.01% | 4709 |
|
|
2021
Q4 | $299K | Buy |
57,676
+47,253
| +453% | +$245K | ﹤0.01% | 4782 |
|
|
2021
Q3 | $64K | Buy |
+10,423
| New | +$64K | ﹤0.01% | 5139 |
|
|
2021
Q1 | – | Sell |
-122,500
| Closed | -$1.33M | – | 5319 |
|
|
2020
Q4 | $1.33M | Buy |
+122,500
| New | +$1.33M | ﹤0.01% | 3302 |
|